Cargando…
Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
Triple‐negative breast cancer (TNBC), the most refractory subtype of breast cancer to current treatments, accounts disproportionately for the majority of breast cancer‐related deaths. This is largely due to cancer plasticity and the development of cancer stem cells (CSCs). Recently, distinct yet int...
Autores principales: | Sulaiman, Andrew, McGarry, Sarah, Li, Li, Jia, Deyong, Ooi, Sarah, Addison, Christina, Dimitroulakos, Jim, Arnaout, Angel, Nessim, Carolyn, Yao, Zemin, Ji, Guang, Song, Haiyan, Gadde, Suresh, Li, Xuguang, Wang, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891054/ https://www.ncbi.nlm.nih.gov/pubmed/29316250 http://dx.doi.org/10.1002/1878-0261.12167 |
Ejemplares similares
-
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
por: Sulaiman, Andrew, et al.
Publicado: (2018) -
Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells
por: Sulaiman, Andrew, et al.
Publicado: (2020) -
An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
por: Jia, Deyong, et al.
Publicado: (2017) -
Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer()()
por: Hasim, Mohamed S., et al.
Publicado: (2018) -
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature
por: El-Sahli, Sara, et al.
Publicado: (2021)